Your browser doesn't support javascript.
loading
Population screening shows risk of inherited cancer and familial hypercholesterolemia in Oregon.
O'Brien, Timothy D; Potter, Amiee B; Driscoll, Catherine C; Goh, Gregory; Letaw, John H; McCabe, Sarah; Thanner, Jane; Kulkarni, Arpita; Wong, Rossana; Medica, Samuel; Week, Tiana; Buitrago, Jacob; Larson, Aaron; Camacho, Katie Johnson; Brown, Kim; Crist, Rachel; Conrad, Casey; Evans-Dutson, Sara; Lutz, Ryan; Mitchell, Asia; Anur, Pavana; Serrato, Vanessa; Shafer, Autumn; Marriott, Lisa K; Hamman, K J; Mulford, Amelia; Wiszniewski, Wojciech; Sampson, Jone E; Adey, Andrew; O'Roak, Brian J; Harrington, Christina A; Shannon, Jackilen; Spellman, Paul T; Richards, C Sue.
Affiliation
  • O'Brien TD; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA.
  • Potter AB; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA.
  • Driscoll CC; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA.
  • Goh G; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA.
  • Letaw JH; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA.
  • McCabe S; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA.
  • Thanner J; Information Technology Group, Oregon Health & Science University, Portland, OR 97201, USA.
  • Kulkarni A; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA.
  • Wong R; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA.
  • Medica S; Integrated Genomics Laboratory, Oregon Health & Science University, Portland, OR 97239, USA.
  • Week T; Integrated Genomics Laboratory, Oregon Health & Science University, Portland, OR 97239, USA.
  • Buitrago J; Integrated Genomics Laboratory, Oregon Health & Science University, Portland, OR 97239, USA.
  • Larson A; Integrated Genomics Laboratory, Oregon Health & Science University, Portland, OR 97239, USA.
  • Camacho KJ; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA.
  • Brown K; Knight Cancer Institute, Community Outreach and Engagement, Oregon Health & Science University, Portland, OR 97201, USA.
  • Crist R; Knight Cancer Institute, Community Outreach and Engagement, Oregon Health & Science University, Portland, OR 97201, USA.
  • Conrad C; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA.
  • Evans-Dutson S; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA.
  • Lutz R; Knight Cancer Institute, Community Outreach and Engagement, Oregon Health & Science University, Portland, OR 97201, USA.
  • Mitchell A; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA.
  • Anur P; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA.
  • Serrato V; Knight Cancer Institute, Community Outreach and Engagement, Oregon Health & Science University, Portland, OR 97201, USA.
  • Shafer A; University of Oregon, School of Journalism and Communication, Portland, OR 97209, USA.
  • Marriott LK; OHSU-PSU School of Public Health, Portland, OR 97239, USA.
  • Hamman KJ; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
  • Mulford A; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
  • Wiszniewski W; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
  • Sampson JE; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
  • Adey A; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
  • O'Roak BJ; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
  • Harrington CA; Integrated Genomics Laboratory, Oregon Health & Science University, Portland, OR 97239, USA; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
  • Shannon J; Knight Cancer Institute, Community Outreach and Engagement, Oregon Health & Science University, Portland, OR 97201, USA; Division of Oncological Sciences, Oregon Health & Science University, Portland, OR 97239, USA.
  • Spellman PT; Cancer Early Detection Advanced Research Center, Knight Cancer Institute, Oregon Health & Science University, Portland, OR 97201, USA; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA.
  • Richards CS; Knight Diagnostic Laboratories, Oregon Health & Science University, Portland, OR 97239, USA; Department of Molecular & Medical Genetics, Oregon Health & Science University, Portland, OR 97239, USA. Electronic address: richarsu@ohsu.edu.
Am J Hum Genet ; 110(8): 1249-1265, 2023 08 03.
Article in En | MEDLINE | ID: mdl-37506692

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyperlipoproteinemia Type II / Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Hum Genet Year: 2023 Document type: Article Affiliation country: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Hyperlipoproteinemia Type II / Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Prognostic_studies / Risk_factors_studies / Screening_studies Limits: Humans Country/Region as subject: America do norte Language: En Journal: Am J Hum Genet Year: 2023 Document type: Article Affiliation country: Estados Unidos